For UK HealthTech companies
NHS innovation programmes are a distribution channel, are you treating them as one?
Fellows of the NHS's flagship accelerator have collectively raised significant investment. These pathways are credibility signals and routes to adoption, not just funding applications, and most healthtech firms miss that entirely.
Two minutes. Solva follows up with specific NHS innovation pathway options.
- HealthTech companies submitting applications to NHS innovation programmes without tailoring their narrative to current NHS strategic priorities
- Products struggling to gain traction in the private sector due to a lack of independent clinical validation or trust signals
- Prolonged sales cycles with private healthcare providers who seek evidence of NHS adoption or regulatory endorsement
- Missed opportunities for co-development or pilot projects with NHS trusts that could de-risk private sector deployment.
- Inefficient resource allocation towards unaligned market entry strategies
- Slower product iteration and adaptation due to delayed real-world feedback from large-scale NHS deployments
- Higher customer acquisition costs in the private sector due to lack of NHS credibility
- Delayed revenue generation from prolonged market entry and adoption cycles
- Perception as a less credible or unproven solution compared to competitors with NHS endorsements
- Difficulty attracting top talent who prefer working on solutions with demonstrable impact and widespread adoption
NIA supported innovations have reached 3,500 new NHS sites (NHS Innovation Accelerator 10-year impact report, 2026)
Frequently asked questions
Why does this problem persist?
Programmes like the NHS Innovation Accelerator, Health Innovation Networks, and NHS England's innovation service are not just funding routes - they are credibility signals and distribution channels. Most healthtech companies treat them as grant applications rather than as marketing infrastructure.
What is the cost of leaving it unaddressed?
NIA fellows have raised over £243 million in investment (NHS Innovation Accelerator 10-year impact report, 2026)
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.